Annexon Inc logo

Annexon Inc

1
1
NAS:ANNX (USA)   Ordinary Shares
$ 5.98 -0.09 (-1.48%) 04:00 PM EST
At Loss
P/B:
1.87
Market Cap:
$ 538.35M
Enterprise V:
$ 318.09M
Volume:
1.30M
Avg Vol (2M):
1.90M
Volume:
1.30M
At Loss
Avg Vol (2M):
1.90M

Business Description

Annexon Inc logo
Annexon Inc
NAICS : 541714 SIC : 2834
ISIN : US03589W1027

Share Class Description:

ANNX: Ordinary Shares
Description
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.
Name Current Vs Industry Vs History
Cash-To-Debt 8.28
Equity-to-Asset 0.84
Debt-to-Equity 0.13
Debt-to-EBITDA -0.22
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 33.92
9-Day RSI 43.89
14-Day RSI 48.75
6-1 Month Momentum % 140.64
12-1 Month Momentum % -4.66

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 14.72
Quick Ratio 14.72
Cash Ratio 14.49

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -27.1
Shareholder Yield % -2.81
Name Current Vs Industry Vs History
ROE % -64.65
ROA % -52.1
ROIC % -346.84
ROC (Joel Greenblatt) % -417.85
ROCE % -60.38

Financials (Next Earnings Date:2024-05-08 Est.)

ANNX's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ANNX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Annexon Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -1.77
Beta 0.9
Volatility % 114.64
14-Day RSI 48.75
14-Day ATR ($) 0.601189
20-Day SMA ($) 6.505
12-1 Month Momentum % -4.66
52-Week Range ($) 1.57 - 8.4
Shares Outstanding (Mil) 90.03

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Annexon Inc Filings

Filing Date Document Date Form
No Filing Data

Annexon Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Annexon Inc Frequently Asked Questions

What is Annexon Inc(ANNX)'s stock price today?
The current price of ANNX is $5.98. The 52 week high of ANNX is $8.40 and 52 week low is $1.57.
When is next earnings date of Annexon Inc(ANNX)?
The next earnings date of Annexon Inc(ANNX) is 2024-05-08 Est..
Does Annexon Inc(ANNX) pay dividends? If so, how much?
Annexon Inc(ANNX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1